Episode #104: Revolutionizing Pain Management: The Power of Low-Level Lasers

About the Guest(s):

James Shanks is the Head of the Medical Laser Division at Erchonia Corporation. With years of experience in the laser therapy industry, James plays a crucial role in expanding the understanding and application of low-level laser therapy (LLLT) within the mainstream medical community. His work bridges the gap between alternative medicine and conventional medical practices, introducing innovative laser treatments to a broader audience of healthcare professionals.

Episode Summary:

In this enlightening episode of the Laser Light Show, Dr. Chad Woolner and Dr. Andrew Wells sit down with James Shanks, the Head of the Medical Laser Division at Erchonia. The discussion dives deep into the advancements and applications of low-level laser therapy (LLLT) across various medical fields.

James Shanks provides a comprehensive overview of Erchonia's journey, highlighting their pioneering work in obtaining FDA clearances that push LLLT into mainstream medical practices. The conversation covers how this technology, initially restricted to alternative medicine, is now finding its way into traditional medical settings like dermatology, orthopedics, and even aesthetic medicine due to its efficacy and safety. The episode offers valuable insights for medical practitioners considering integrating this revolutionary technology into their practices.

Key Takeaways:

• Expanding LLLT in Mainstream Medicine: James Shanks discusses the evolution of low-level laser therapy from alternative medicine to mainstream medical applications, emphasizing its potential for diverse medical fields.

• FDA Clearances and Research: The extensive research and numerous FDA clearances obtained by Erchonia underline the legitimacy, safety, and efficacy of their lasers.

• Clinical Application and Mechanisms: Insights into how LLLT works at a biochemical level to promote healing, reduce pain, and support regenerative medicine.

• Economic and Practical Considerations: The conversation addresses the challenges and opportunities for medical practitioners transitioning from insurance-based models to cash-based, integrative practices.

• Future Directions: James shares exciting developments and future applications of laser therapy that Erchonia is exploring, promising broader and more innovative uses.

Notable Quotes:

1. "When you start talking and giving them ideas of where it's being applied, just talking about our FDA clearances, not talking about any other types of off labels, uses are being used for laser therapy out there."

2. "We have 22 FDA indications and clearances right now, but we didn't start 22. We've done over 45 FDA clinical trials."

3. "That's the great benefit to them because it seems so new to them... Once they start using it, you can see we're excited about it."

4. "With all of these various providers around them, offering these services, which they really couldn't get a grasp on. That's been around for years, but they never really were taught in medical school."

5. "It either works or it doesn't, you're not going to cause any risk. And I think that's a lot of comfort for you guys as doctors too, knowing that, okay, I can turn this on and maybe there's something, I don't know what to treat, but I can at least try it just because of the mechanism of the lasers and how they work."

Resources:

• Erchonia Corporation Website

• Clinical Trials - Erchonia

• Laser Therapy Research on Pubmed

Join us for this fascinating dive into the world of low-level laser therapy, and discover how these cutting-edge technologies can revolutionize patient care. For mor